These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8883616)

  • 1. The role of the humoral immune response in HIV infection.
    Fenyö EM; Albert J; McKeating J
    AIDS; 1996; 10 Suppl A():S97-106. PubMed ID: 8883616
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV specific humoral immune response in Rio de Janeiro, Brazil. The HEC/Fiocruz AIDS Clinical Research Group.
    Bongertz V; Costa CI; Guimarães ML; Soares-da-Costa MF; Grinsztejn B; Bastos FI; Pilotto JH; João Filho EC; Loureiro R; Chequer P; Telles PR; Galvão-Castro B; Morgado MG
    Mem Inst Oswaldo Cruz; 1998; 93(3):391-8. PubMed ID: 9698875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization.
    Georgiev IS; Doria-Rose NA; Zhou T; Kwon YD; Staupe RP; Moquin S; Chuang GY; Louder MK; Schmidt SD; Altae-Tran HR; Bailer RT; McKee K; Nason M; O'Dell S; Ofek G; Pancera M; Srivatsan S; Shapiro L; Connors M; Migueles SA; Morris L; Nishimura Y; Martin MA; Mascola JR; Kwong PD
    Science; 2013 May; 340(6133):751-6. PubMed ID: 23661761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV superinfection in women may boost immune response.
    Rose S
    Expert Rev Anti Infect Ther; 2012 May; 10(5):525. PubMed ID: 22702314
    [No Abstract]   [Full Text] [Related]  

  • 5. Humoral immunity to HIV-1: neutralization and beyond.
    Huber M; Trkola A
    J Intern Med; 2007 Jul; 262(1):5-25. PubMed ID: 17598812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children.
    Broliden K; Sievers E; Tovo PA; Moschese V; Scarlatti G; Broliden PA; Fundaro C; Rossi P
    Clin Exp Immunol; 1993 Jul; 93(1):56-64. PubMed ID: 8324904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV/AIDS: allied responses.
    Mascola JR
    Nature; 2007 Sep; 449(7158):29-30. PubMed ID: 17805280
    [No Abstract]   [Full Text] [Related]  

  • 8. New insights into protective humoral responses and HIV vaccines.
    Stamatatos L; Davis D
    AIDS; 2001; 15 Suppl 5():S105-15. PubMed ID: 11816158
    [No Abstract]   [Full Text] [Related]  

  • 9. Importance of anti-HIV-1 antibodies.
    Karpas A; Ash S; Bainbridge D
    Nat Med; 1997 Jun; 3(6):590-1. PubMed ID: 9176475
    [No Abstract]   [Full Text] [Related]  

  • 10. Human monoclonal antibodies to HIV-1 define synergistic activities leading to enhanced neutralization.
    Zolla-Pazner S; Laal S; Burda S; Buchbinder A
    Antibiot Chemother (1971); 1994; 46():38-47. PubMed ID: 7826038
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement-mediated, antibody-dependent neutralizing titers of sera from asymptomatic and symptomatic HIV-infected individuals.
    Spear GT; Carlson JR; Jennings MB; Takefman DM; Landay AL
    AIDS; 1992 Sep; 6(9):1047. PubMed ID: 1388899
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV-1 cross-neutralizing antibodies in German HIV-1-infected patients do not correlate with an antibody-binding pattern against different HIV-1 isolates.
    Jurkiewicz E; Petry H; Sutor GC; Lang S; Schedel I; Hunsmann G
    AIDS; 1995 Jan; 9(1):91-3. PubMed ID: 7893448
    [No Abstract]   [Full Text] [Related]  

  • 13. Native HIV type 1 virion surface structures: relationships between antibody binding and neutralization or lessons from the viral capture assay.
    Cavacini L; Posner M
    AIDS Res Hum Retroviruses; 2004 Apr; 20(4):435-41. PubMed ID: 15157362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of neutralizing antibodies in HIV infection.
    Humbert M; Dietrich U
    AIDS Rev; 2006; 8(2):51-9. PubMed ID: 16848273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What's new in HIV/AIDS? Neutralizing HIV antibodies: do they really protect?
    Jülg B; Goebel FD
    Infection; 2005 Oct; 33(5-6):405-7. PubMed ID: 16258878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1MN recombinant gp120 vaccine serum, which fails to neutralize primary isolates of HIV-1, does not antagonize neutralization by antibodies from infected individuals.
    Wrin T; Nunberg JH
    AIDS; 1994 Nov; 8(11):1622-3. PubMed ID: 7848602
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course.
    Beaumont T; van Nuenen A; Broersen S; Blattner WA; Lukashov VV; Schuitemaker H
    J Virol; 2001 Mar; 75(5):2246-52. PubMed ID: 11160728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virology. HIV may shed some protection as it jumps to new hosts.
    Cohen J
    Science; 2004 Mar; 303(5666):1956. PubMed ID: 15044774
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.
    Polonis VR; Brown BK; Rosa Borges A; Zolla-Pazner S; Dimitrov DS; Zhang MY; Barnett SW; Ruprecht RM; Scarlatti G; Fenyö EM; Montefiori DC; McCutchan FE; Michael NL
    Virology; 2008 Jun; 375(2):315-20. PubMed ID: 18367229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular dendritic cells and human immunodeficiency virus infectivity.
    Heath SL; Tew JG; Tew JG; Szakal AK; Burton GF
    Nature; 1995 Oct; 377(6551):740-4. PubMed ID: 7477265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.